What is the treatment for severe hyperglycemia (high blood sugar) with a glucose level over 500 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Severe Hyperglycemia with Glucose >500 mg/dL

For severe hyperglycemia with glucose levels over 500 mg/dL, immediate intravenous insulin infusion is the most appropriate treatment, followed by transition to a basal-bolus insulin regimen once stabilized. 1

Initial Management

Immediate Treatment

  • Start continuous intravenous regular insulin infusion:
    • Adult patients: Initial IV bolus of regular insulin at 0.15 units/kg body weight, followed by continuous infusion at 0.1 unit/kg/hour (typically 5-7 units/hour) 2
    • Pediatric patients: No initial bolus; start continuous infusion at 0.1 unit/kg/hour 2
    • Monitor glucose every 30 minutes to 2 hours until stable 1

Fluid Replacement

  • Initiate aggressive fluid replacement:
    • Start with isotonic saline (0.9% NaCl) at 10-20 mL/kg/hour for the first hour 2
    • In severely dehydrated patients, this may need to be repeated, but initial rehydration should not exceed 50 mL/kg over first 4 hours 2
    • After initial rehydration, switch to 0.45-0.9% NaCl (depending on serum sodium) 2

Electrolyte Management

  • Monitor and replace potassium:
    • Once renal function is confirmed and serum potassium is known, add 20-40 mEq/L potassium to IV fluids 2
    • Monitor for hypokalemia, which is common during treatment of hyperglycemic crises 1

Monitoring During Treatment

  • Check blood glucose every 30 minutes to 2 hours during IV insulin therapy 1
  • Monitor electrolytes, especially potassium, every 2-4 hours 2
  • Assess mental status regularly to identify complications 2
  • Target glucose range: 140-180 mg/dL for most patients 2

Transition from IV to Subcutaneous Insulin

  1. Calculate total daily dose (TDD) based on average insulin infusion rate over previous 12 hours 1
  2. Administer subcutaneous insulin 1-2 hours before discontinuing IV insulin to prevent rebound hyperglycemia 1
  3. Convert to basal insulin at 60-80% of the daily infusion dose 1
  4. Implement basal-bolus regimen (not sliding scale alone) 1
    • 50% as basal insulin (long-acting)
    • 50% as prandial insulin (rapid-acting) divided between meals 1

Maintenance Regimen

  • Basal-bolus insulin regimen:

    • Basal insulin: Once-daily long-acting insulin
    • Prandial insulin: Rapid-acting insulin before meals (starting with 4-6 units per meal) 1
    • Correction doses: Additional insulin based on pre-meal glucose readings 1
  • Target glucose range:

    • 140-180 mg/dL for most hospitalized patients 2
    • More stringent goals (110-140 mg/dL) may be appropriate for selected patients if achievable without significant hypoglycemia 2

Common Pitfalls to Avoid

  1. Relying solely on sliding-scale insulin - This reactive approach treats hyperglycemia after it occurs rather than preventing it 1

  2. Improper transition from IV to subcutaneous insulin - Can lead to rebound hyperglycemia; always overlap subcutaneous and IV insulin by 1-2 hours 1

  3. Inadequate total insulin dose - Failure to adjust both basal and bolus components leads to poor glucose control 1

  4. Too rapid correction of glucose - May lead to cerebral edema, especially in pediatric patients 2

  5. Neglecting potassium monitoring - Insulin therapy can cause hypokalemia 3

Special Considerations

  • For patients with glucose >500 mg/dL but who are clinically stable with mild symptoms, outpatient management with subcutaneous insulin may be considered 2

  • For patients with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), additional specific protocols should be followed 2

  • Patients with severe hyperglycemia should be evaluated for precipitating factors such as infection, medication non-adherence, or new-onset diabetes 3

Remember that severe hyperglycemia (>500 mg/dL) represents a medical emergency that requires prompt treatment to prevent life-threatening complications. The cornerstone of management is insulin therapy, fluid replacement, and careful monitoring.

References

Guideline

Management of Hyperglycemia in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.